Coregistration of 18F-FDG-PET and MRI in the Staging of Potentially Resectable Hilar Cholangiocarcinoma: a Pilot Study (PET/MRCP)
This study has been withdrawn prior to enrollment.
University of Toronto
First Posted: January 30, 2008
Last Update Posted: May 4, 2017
University Health Network, Toronto
Information provided by (Responsible Party):
Ur Metser, University of Toronto